More Australian Clinical Labs Ltd news
Australian Clinical Labs LtdASX: ACL

HLS: ACCC Statement of Issues

Jul 20, 2023 at 6:09 AM EDT · Issued by Australian Clinical Labs Ltd

Filed with ASX · Jul 20, 2023 at 6:09 AM EDT

On 6ix: 6ix.com/news/hls-accc-statement-of-issues-1

Australian Clinical Labs Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Australian Clinical Labs Ltd on 6ix

Earlier from Australian Clinical Labs

  • Takeover bid for Healius Ltd- extension of offer periodJul 20, 2023
  • AXX: ACL's proposed acquisition of Healius raises concernsJul 20, 2023
  • HLS: Directors' Statement re TakeoverMay 22, 2023
  • Response to Healius' Target's StatementMay 22, 2023
  • Second Supplementary Bidder's StatementMay 22, 2023

Later from Australian Clinical Labs

  • Appendix 4E and FY23 financial reportsAug 21, 2023
  • FY23 investor results presentationAug 21, 2023
  • HLS: Supplementary Target's StatementSep 4, 2023
  • Third Supplementary Bidder's StatementOct 8, 2023
  • Notice of fulfilment of conditionsOct 8, 2023
All Australian Clinical Labs news releases↗

Follow Australian Clinical Labs into a list and get an email when it puts out news.

Follow Australian Clinical Labs
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer